Published in Gastroenterology on December 01, 2001
Clinical practice. Gastroesophageal reflux disease. N Engl J Med (2008) 3.30
American Gastroenterological Association technical review on the management of Barrett's esophagus. Gastroenterology (2011) 2.50
Is esophageal adenocarcinoma occurring late after antireflux surgery due to persistent postoperative reflux? World J Surg (2007) 2.07
Adenocarcinoma of oesophagus: what exactly is the size of the problem and who is at risk? Gut (2005) 1.74
Gastric cancer: descriptive epidemiology, risk factors, screening, and prevention. Cancer Epidemiol Biomarkers Prev (2014) 1.73
Barrett's adenocarcinoma of the esophagus: better outcomes through new methods of diagnosis and treatment. Dtsch Arztebl Int (2011) 1.72
Gastric acid suppression and risk of oesophageal and gastric adenocarcinoma: a nested case control study in the UK. Gut (2006) 1.67
Studies of acid exposure immediately above the gastro-oesophageal squamocolumnar junction: evidence of short segment reflux. Gut (2004) 1.67
Bile acids as endogenous etiologic agents in gastrointestinal cancer. World J Gastroenterol (2009) 1.63
Cigarette smoking and adenocarcinomas of the esophagus and esophagogastric junction: a pooled analysis from the international BEACON consortium. J Natl Cancer Inst (2010) 1.60
Antireflux surgery, barrett esophagus, and adenocarcinoma: there is still room for doubt. Ann Surg (2007) 1.44
Predictors of progression in Barrett's esophagus: current knowledge and future directions. Am J Gastroenterol (2010) 1.35
Field defects in progression to gastrointestinal tract cancers. Cancer Lett (2007) 1.28
Psychosocial working conditions and the risk of esophageal and gastric cardia cancers. Eur J Epidemiol (2004) 1.18
ErbB receptors in the biology and pathology of the aerodigestive tract. Exp Cell Res (2008) 1.17
Barrett's esophagus and the increasing role of endoluminal therapy. Therap Adv Gastroenterol (2008) 1.11
Risk factors for the gastric cardia cancer: a case-control study in Fujian Province. World J Gastroenterol (2003) 1.07
Barrett's oesophagus and oesophageal adenocarcinoma: how does acid interfere with cell proliferation and differentiation? Gut (2005) 1.03
Pathogenesis of columnar-lined esophagus. World J Gastroenterol (2006) 1.02
The effect of antireflux surgery on esophageal carcinogenesis in patients with barrett esophagus: a systematic review. Ann Surg (2007) 1.00
Have patients with esophagitis got an increased risk of adenocarcinoma? Results from a population-based study. World J Gastroenterol (2005) 0.98
Impact of the biliary diversion procedure on carcinogenesis in Barrett's esophagus surgically induced by duodenoesophageal reflux in rats. Ann Surg (2004) 0.93
Hyperactivation of Akt/mTOR and deficiency in tuberin increased the oxidative DNA damage in kidney cancer patients with diabetes. Oncotarget (2014) 0.92
Diabetes and risk of renal cell carcinoma. J Cancer (2011) 0.91
Shape of Barrett's epithelium is associated with prevalence of erosive esophagitis. World J Gastroenterol (2010) 0.88
Diet and lifestyle factors and risk of subtypes of esophageal and gastric cancers: classification tree analysis. Ann Epidemiol (2013) 0.87
Upper gastrointestinal cancer and reflux disease. J Gastric Cancer (2013) 0.86
Pathophysiology and treatment of Barrett's esophagus. World J Gastroenterol (2010) 0.85
Barrett's oesophagus: an ideal model to study cancer genetics. Hum Genet (2009) 0.84
Current Strategies in the management of Barrett's esophagus. Curr Gastroenterol Rep (2005) 0.84
Relationship between body mass index and the risk of early gastric cancer and dysplasia regardless of Helicobacter pylori infection. Gastric Cancer (2014) 0.83
Barrett's esophagus with high-grade dysplasia: focus on current treatment options. World J Gastroenterol (2011) 0.82
Antireflux surgery and adenocarcinoma of the esophagus: let the truth be told. Gastroenterology (2001) 0.80
A new three-layer-funnel-shaped esophagogastric anastomosis for surgical treatment of esophageal carcinoma. World J Gastroenterol (2003) 0.80
Multilayered epithelium may be found in patients with Barrett's epithelium and dysplasia or adenocarcinoma. Dig Dis Sci (2006) 0.80
Management strategies of Barrett's esophagus. World J Gastroenterol (2012) 0.79
No excess risk of colorectal cancer among alcoholics followed for up to 25 years. Br J Cancer (2003) 0.78
Two distinct etiologies of gastric cardia adenocarcinoma: interactions among pH, Helicobacter pylori, and bile acids. Front Microbiol (2015) 0.77
Evaluation of routine biopsies in endoscopic screening for esophagogastric junction cancer. World J Gastroenterol (2014) 0.77
Risk factors for neoplastic progression in Barrett's esophagus. World J Gastroenterol (2011) 0.77
Barrett's oesophagus: frequency and prediction of dysplasia and cancer. Best Pract Res Clin Gastroenterol (2015) 0.76
Oesophageal cancer and gastro-oesophageal reflux: what is the relationship? Gut (2004) 0.76
Microarray profile of human kidney from diabetes, renal cell carcinoma and renal cell carcinoma with diabetes. Genes Cancer (2015) 0.75
MDM4 genetic variants and risk of gastric cancer in an eastern chinese population. Oncotarget (2017) 0.75
Body mass index, serum total cholesterol, and risk of gastric high-grade dysplasia: A case-control study among Chinese adults. Medicine (Baltimore) (2016) 0.75
Membrane bile acid receptor TGR5 predicts good prognosis in ampullary adenocarcinoma patients with hyperbilirubinemia. Oncol Rep (2016) 0.75
Health-related quality of life in patients with Barrett's esophagus. Health Qual Life Outcomes (2016) 0.75
How should Barrett's ulceration be treated? Surg Endosc (2004) 0.75
Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med (1999) 17.30
Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature (2000) 8.96
Effect of adenosine on atrioventricular (AV) conduction. Pacing Clin Electrophysiol (1990) 5.83
Comprehensive statistical study of 452 BRCA1 missense substitutions with classification of eight recurrent substitutions as neutral. J Med Genet (2005) 4.98
The risk of stomach cancer in patients with gastric or duodenal ulcer disease. N Engl J Med (1996) 4.81
Tobacco, alcohol, and socioeconomic status and adenocarcinomas of the esophagus and gastric cardia. J Natl Cancer Inst (1997) 4.09
Host response to EBV infection in X-linked lymphoproliferative disease results from mutations in an SH2-domain encoding gene. Nat Genet (1998) 3.94
Irritable bowel syndrome and dyspepsia in the general population: overlap and lack of stability over time. Gastroenterology (1995) 3.86
Cancer incidence in a population-based cohort of patients hospitalized with diabetes mellitus in Denmark. J Natl Cancer Inst (1997) 3.57
Risk of connective tissue disease and related disorders among women with breast implants: a nation-wide retrospective cohort study in Sweden. BMJ (1998) 3.34
Association between body mass and adenocarcinoma of the esophagus and gastric cardia. Ann Intern Med (1999) 3.31
Acetaminophen, aspirin, and chronic renal failure. N Engl J Med (2001) 3.28
Disruption of the Jak1 gene demonstrates obligatory and nonredundant roles of the Jaks in cytokine-induced biologic responses. Cell (1998) 3.25
Helicobacter pylori infection in Swedish school children: lack of evidence of child-to-child transmission outside the family. Gastroenterology (2001) 3.17
Evaluating gastric cancer misclassification: a potential explanation for the rise in cardia cancer incidence. J Natl Cancer Inst (1999) 3.13
A prospective study of obesity and cancer risk (Sweden). Cancer Causes Control (2001) 3.13
Identification of functional clusters of transcription factor binding motifs in genome sequences: the MSCAN algorithm. Bioinformatics (2003) 2.84
Excess risk of primary liver cancer in patients with diabetes mellitus. J Natl Cancer Inst (1996) 2.78
Drug treatment of functional dyspepsia: a systematic analysis of trial methodology with recommendations for design of future trials. Am J Gastroenterol (1996) 2.73
Population attributable risk of renal cell cancer in Minnesota. Am J Epidemiol (1998) 2.65
Helicobacter pylori infection: independent risk indicator of gastric adenocarcinoma. Gastroenterology (1993) 2.64
Mesenteric cysts and intra-abdominal cystic lymphangiomas. Arch Surg (1985) 2.62
The role of tobacco, snuff and alcohol use in the aetiology of cancer of the oesophagus and gastric cardia. Int J Cancer (2000) 2.58
Rapid healing of duodenal ulcers with omeprazole: double-blind dose-comparative trial. Lancet (1983) 2.51
Extended abdominoperineal resection with gluteus maximus flap reconstruction of the pelvic floor for rectal cancer. Br J Surg (2007) 2.47
Use of aspirin and other nonsteroidal anti-inflammatory drugs and risk of esophageal and gastric cancer. Cancer Epidemiol Biomarkers Prev (1998) 2.43
Cyclosporine A-resistant human immunodeficiency virus type 1 mutants demonstrate that Gag encodes the functional target of cyclophilin A. J Virol (1996) 2.39
The epidermal growth factor receptor regulates interaction of the human DF3/MUC1 carcinoma antigen with c-Src and beta-catenin. J Biol Chem (2001) 2.37
The role of Gag in human immunodeficiency virus type 1 virion morphogenesis and early steps of the viral life cycle. J Virol (1996) 2.31
Temporal patterns in colorectal cancer incidence, survival, and mortality from 1950 through 1990. J Natl Cancer Inst (1994) 2.31
Inverse association between intake of cereal fiber and risk of gastric cardia cancer. Gastroenterology (2001) 2.30
The luminal short-chain fatty acid butyrate modulates NF-kappaB activity in a human colonic epithelial cell line. Gastroenterology (2000) 2.27
Genetic polymorphism in exon 4 of cytochrome P450 CYP2C9 may be associated with warfarin sensitivity in Chinese patients. Blood (2001) 2.26
AGA technical review: evaluation of dyspepsia. American Gastroenterological Association. Gastroenterology (1998) 2.19
No relation between body mass and gastro-oesophageal reflux symptoms in a Swedish population based study. Gut (2000) 2.16
Nutrient intake and risk of subtypes of esophageal and gastric cancer. Cancer Epidemiol Biomarkers Prev (2001) 2.13
Venous thromboembolism and cancer. Lancet (1998) 2.08
Rural-urban differences in stage at diagnosis. Possible relationship to cancer screening. Cancer (1991) 2.08
Risk of urinary tract cancers following kidney or ureter stones. J Natl Cancer Inst (1997) 2.06
The influence of cigarette smoking, alcohol, and green tea consumption on the risk of carcinoma of the cardia and distal stomach in Shanghai, China. Cancer (1996) 2.05
Cost-effectiveness of palliative chemotherapy in advanced gastrointestinal cancer. Ann Oncol (1995) 2.01
No survival benefit from early-start dialysis in a population-based, inception cohort study of Swedish patients with chronic kidney disease. J Intern Med (2010) 2.01
Gastroesophageal reflux disease, use of H2 receptor antagonists, and risk of esophageal and gastric cancer. Cancer Causes Control (2000) 2.00
Body size and prostate cancer: a 20-year follow-up study among 135006 Swedish construction workers. J Natl Cancer Inst (1997) 1.98
Sunlight and non-Hodgkin's lymphoma: a population-based cohort study in Sweden. Int J Cancer (1999) 1.97
Initial or delayed chemotherapy with best supportive care in advanced gastric cancer. Ann Oncol (1994) 1.96
PACS databases and enrichment of the folder manager concept. J Digit Imaging (2000) 1.95
Correlates of homosexual behavior and the incidence of anal cancer. JAMA (1982) 1.95
Helicobacter pylori in gastric cancer established by CagA immunoblot as a marker of past infection. Gastroenterology (2001) 1.87
Cancer incidence trends in urban shanghai, 1972-1994: an update. Int J Cancer (1999) 1.83
Association between medications that relax the lower esophageal sphincter and risk for esophageal adenocarcinoma. Ann Intern Med (2000) 1.83
Absence of therapeutic benefit from antacids or cimetidine in non-ulcer dyspepsia. N Engl J Med (1986) 1.79
Decline in the incidence of carcinoma in situ of the cervix. Am J Public Health (1986) 1.78
Transcatheter closure of atrial septal defect using Amplatzer septal occluder in Chinese adults. Catheter Cardiovasc Interv (2001) 1.77
Calculating biological behaviors of epigenetic states in the phage lambda life cycle. Funct Integr Genomics (2004) 1.74
Risk factors for oesophageal cancer in northeast China. Int J Cancer (1994) 1.73
The role of interleukin-1 polymorphisms in the pathogenesis of gastric cancer. Nature (2001) 1.71
Primary tubal infertility in relation to the use of an intrauterine device. N Engl J Med (1985) 1.69
Diabetes mellitus and risk of large bowel cancer. J Natl Cancer Inst (1997) 1.68
Gastric acid suppression and risk of oesophageal and gastric adenocarcinoma: a nested case control study in the UK. Gut (2006) 1.67
Long-term health-related quality of life following surgery for oesophageal cancer. Br J Surg (2008) 1.64
A cohort study of cancer among benzene-exposed workers in China: overall results. Am J Ind Med (1996) 1.63
Risk of pancreatic cancer following diabetes mellitus: a nationwide cohort study in Sweden. J Natl Cancer Inst (1995) 1.62
Increasing incidence of both major histological types of esophageal carcinomas among men in Sweden. Int J Cancer (1993) 1.57
Blocked and nonblocked acid secretion and reported pain in ulcer, nonulcer dyspepsia, and normal subjects. Gastroenterology (1989) 1.53
The risk of esophageal cancer in patients with achalasia. A population-based study. JAMA (1995) 1.51
A nationwide study of the use of self-expanding stents in patients with esophageal cancer in Sweden. Endoscopy (2005) 1.51
Pancreatitis and pancreatic cancer: a population-based study. J Natl Cancer Inst (1994) 1.49
Morbidity and mortality before and after bariatric surgery for morbid obesity compared with the general population. Br J Surg (2011) 1.48
Lifestyle related risk factors in the aetiology of gastro-oesophageal reflux. Gut (2004) 1.47
Does the method of Helicobacter pylori detection influence the association with gastric cancer risk? Scand J Gastroenterol (2002) 1.46
The role of diabetes mellitus in the aetiology of renal cell cancer. Diabetologia (1999) 1.45
Lifestyle and endometrial cancer risk: a cohort study from the Swedish Twin Registry. Int J Cancer (1999) 1.44
A multimycotoxin detection method for aflatoxins, ochratoxins, zearalenone, sterigmatocystin, and patulin. J Assoc Off Anal Chem (1971) 1.44
Population-based study of the need for cholecystectomy after obesity surgery. Br J Surg (2012) 1.42
Cerebral palsy in southern Sweden I. Prevalence and clinical features. Acta Paediatr (2001) 1.42
Risk of endometrial and breast cancer in patients with diabetes mellitus. Int J Cancer (1997) 1.42
Dietary factors and the risk of pancreatic cancer: a case-control study in Shanghai China. Cancer Epidemiol Biomarkers Prev (1995) 1.41
Diagnostic value of aberrant gene methylation in stool samples for colorectal cancer or adenomas: a meta-analysis. Panminerva Med (2014) 1.40
Control definition in case-control studies of ectopic pregnancy. Am J Public Health (1985) 1.40
Increasing incidence of carcinoma of the gastric cardia in Sweden from 1970 to 1985. Br J Surg (1993) 1.40
Robustness, stability and efficiency of phage lambda genetic switch: dynamical structure analysis. J Bioinform Comput Biol (2004) 1.39
Do sex hormones play a role in the etiology of esophageal adenocarcinoma? A new hypothesis tested in a population-based cohort of prostate cancer patients. Cancer Epidemiol Biomarkers Prev (1998) 1.38
Alcohol abuse and the risk of pancreatic cancer. Gut (2002) 1.35
Reproducibility and validity of a postal questionnaire. The abdominal symptom study. Scand J Prim Health Care (1993) 1.35
Cholecystectomy and colorectal cancer. Gastroenterology (1993) 1.35
The risk of pancreatic cancer following pancreatitis: an association due to confounding? Gastroenterology (1997) 1.34
Dietary habits and stomach cancer in Shanghai, China. Int J Cancer (1998) 1.33
Tobacco, alcohol and the risk of gastric cancer by sub-site and histologic type. Int J Cancer (1999) 1.33
Colorectal cancer incidence trends by subsite in urban Shanghai, 1972-1994. Cancer Epidemiol Biomarkers Prev (1998) 1.33
Spontaneous regression of primary autoreactivity during chronic progression of experimental autoimmune encephalomyelitis and multiple sclerosis. J Exp Med (1999) 1.33
Green tea consumption and the risk of pancreatic and colorectal cancers. Int J Cancer (1997) 1.32
Body mass and reflux oesophagitis: an oestrogen-dependent association? Scand J Gastroenterol (2002) 1.31
Fruit and vegetable consumption in the prevention of oesophageal and cardia cancers. Eur J Cancer Prev (2001) 1.31